A novel class of DHODH inhibitors called tetrahydroindazoles was recently identified in the group of professor Sonia Lain through screening of a commercially available chemical library for activators of p53. The hit compound HZ00 is able to slow tumor cell growth in culture, an effect which was reversed upon supplementation with uridine, and had little […]
Read More